Exploring The Bleeding Disorders Market: Causes, Types, & Treatment

Bleeding disorders are rare disorders in which there is an issue with the body’s blood clotting process. The condition affects the way the body controls blood clotting, leading to heavy and extended bleeding after an injury or surgery. In this blog, we will explore the causes and types of bleeding disorders. We will also provide key statistics on the bleeding disorders market.

Understanding Bleeding Disorders

These disorders can significantly affect a person’s daily life and overall well-being. Clotting factors are proteins in the blood that works with blood clots. When the functioning or number of clotting factors get affected by any problem, it can lead to a bleeding disorder.

The global bleeding disorders market was valued at USD 13.17 billion in 2022 and is expected to reach USD 27.49 billion at a CAGR of 7.7% during the forecast period.

Symptoms

Symptoms of a bleeding disorder include:

• Easy bruising
• Gum bleeding
• Heavy menstrual periods
• Nosebleeds
• Gastrointestinal bleeding
• Bleeding into joints

Treatment

Treatment of bleeding disorders depends on the conditions and severity. For some bleeding disorders, the doctor may recommend medicines or clotting factor replacement therapy. Some bleeding disorders can cause problems, and some are chronic illnesses. Also, some women with bleeding disorders may consume birth control pills to manage heavy periods.

To Get Insights on the Bleeding Disorders Market:  Request for a Sample Report

Types

Types of bleeding disorders

• Acquired platelet function defects
• Congenital platelet function defects
• Disseminated intravascular coagulation (DIC)
• Prothrombin deficiency
• Factor V deficiency
• Factor VII deficiency
• Factor X deficiency
• Factor XI deficiency (hemophilia C)
• Glanzmann disease
• Hemophilia A
• Hemophilia B
• Idiopathic thrombocytopenic purpura (ITP)
• Von Willebrand disease (types I, II, and III)
• Blood donation plays a crucial role

A continuous supply of donated blood and plasma is essential to serve the requirements of patients with bleeding disorders. These clotting factors can only be created with the help of donated blood and plasma. With the rising prevalence of bleeding disorders, the demand for clotting factor replacement therapy rises, which thereby fuels the demand for blood donations. According to research by WHO, from 2008 to 2018, 10.7 million more people gave blood voluntarily and without payment. Overall, 79 countries get more than 90% of their blood supply from unpaid, voluntary donors, but more than 50% of the blood supply in 54 countries comes from paid, family, or replacement donors.

Market Dynamics

The growing incidences of HBV infections are one of the prominent contributors to the bleeding disorders market growth because the demand for clotting factor replacement therapy rises among patients with HBV-related bleeding disorders. The rising prevalence of bleeding disorders such as hemophilia, von Willebrand disease, and other clotting factor deficiencies due to the factors such as aging populations, changing lifestyles, and genetic mutations is further driving the market growth.

Future Outlook

With the introduction of new treatment approaches and personalized medicine, patients' quality of life is improving. The bleeding disorders market is anticipated to continue evolving and expanding in the future, driven by growing technological developments and a surge in access to care globally.

---